MMP14 and Cognitive impairment: To investigate whether this MT1-MMP-induced cognitive impairment was mediated through neuroinflammation, we administered the neuroinflammation suppressor C52 over two weeks in 18-month-old aged mice, which led to significant improvements in several functional outcomes.